Medivir Management
Management criteria checks 1/4
Medivir's CEO is Jens Lindberg, appointed in Jan 2022, has a tenure of 2.33 years. total yearly compensation is SEK7.82M, comprised of 32.8% salary and 67.2% bonuses, including company stock and options. directly owns 0.096% of the company’s shares, worth SEK319.93K. The average tenure of the management team and the board of directors is 3.5 years and 0.8 years respectively.
Key information
Jens Lindberg
Chief executive officer
SEK 7.8m
Total compensation
| CEO salary percentage | 32.8% |
| CEO tenure | 2.3yrs |
| CEO ownership | 0.1% |
| Management average tenure | 3.5yrs |
| Board average tenure | less than a year |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -SEK 97m |
| Dec 31 2023 | SEK 8m | SEK 3m | -SEK 89m |
| Sep 30 2023 | n/a | n/a | -SEK 87m |
| Jun 30 2023 | n/a | n/a | -SEK 78m |
| Mar 31 2023 | n/a | n/a | -SEK 75m |
| Dec 31 2022 | SEK 3m | SEK 2m | -SEK 89m |
Compensation vs Market: Jens's total compensation ($USD730.89K) is above average for companies of similar size in the UK market ($USD354.91K).
Compensation vs Earnings: Jens's compensation has increased whilst the company is unprofitable.
CEO
Jens Lindberg (52 yo)
2.3yrs
Tenure
SEK 7,824,000
Compensation
Mr. Jens Lindberg serves as Chief Executive Officer at Medivir AB (publ) since January 24, 2022. He served as Acting Chief Executive Officer at Sedana Medical AB (publ) since June 1, 2021 until 2021 and se...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 2.3yrs | SEK 7.82m | 0.096% SEK 319.9k | |
| Chief Financial Officer | 4.8yrs | SEK 2.66m | 0.068% SEK 227.2k | |
| Chief Scientific Officer | 4.7yrs | no data | 0.11% SEK 370.5k | |
| Chief Medical Officer | 1.3yrs | no data | 0.046% SEK 152.5k | |
| Senior Principal Scientist & MIV-818 Project Leader | no data | no data | no data |
3.5yrs
Average Tenure
54.5yo
Average Age
Experienced Management: MVIRS's management team is considered experienced (3.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 6yrs | SEK 260.00k | 0.036% SEK 119.6k | |
| Chairman of the Board | 6yrs | SEK 690.00k | 0.89% SEK 3.0m | |
| Director | 3yrs | SEK 260.00k | 0.045% SEK 149.5k | |
| Member of Scientific Advisory Council | less than a year | no data | no data | |
| Independent Director | 7yrs | SEK 260.00k | 0.029% SEK 95.7k | |
| Member of Scientific Advisory Council | less than a year | no data | no data | |
| Member of Scientific Advisory Council | less than a year | no data | no data | |
| Member of Scientific Advisory Council | less than a year | no data | no data | |
| Member of Scientific Advisory Council | less than a year | no data | no data | |
| Director | no data | no data | no data | |
| Director | no data | no data | no data |
0.8yrs
Average Tenure
73yo
Average Age
Experienced Board: MVIRS's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/05/20 12:17 |
| End of Day Share Price | 2024/02/21 00:00 |
| Earnings | 2024/03/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Medivir AB (publ) is covered by 13 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Morten Larsen | ABG Sundal Collier |
| Kristofer Liljeberg-Svensson | Carnegie Investment Bank AB |
| Revi Mehrotra | Credit Suisse |